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Abstract
Background: The real burden of smear-positive (PTB+) and bacteriologically confirmed tuberculosis (BCTB) in
Ethiopia is not known. Thus, the aim of this community-based study was to measure the prevalence and incidence
of tuberculosis in the Hetosa District of Oromia Region, Ethiopia.
Methods: First, a population-based cross-sectional survey was conducted on a total of 33,073 individuals aged ≥ 15
years to determine the prevalence of PTB+ and BCTB cases. Then, in order to determine the incidence, a
prospective follow-up was carried out on 32,800 individuals found to be either free from symptoms suggestive of
TB (SSTB) during the baseline survey or had symptoms suggestive of TB but yielded negative bacteriological
examination results. We identified 1,041 presumptive TB cases at the baseline survey, and 1,468 in the follow-up
study. Each participants with cough of more than two weeks were provided spot and morning sputum samples for
acid-fast bacilli sputum microscopy and culture.
Results: At the baseline survey, 43 BCTB cases were identified. Thirty six of these were both smear- and
culture-positive while seven were only culture-positive. In the follow-up study, however, 76 BCTB cases were
diagnosed and 70 of these were found to be both smear- and culture-positive while six were culture-positive only.
The adjusted prevalence of PTB+ and BCTB in the study area was 109 and 132/100,000 persons, respectively.
Moreover, the incidences of PTB+ and BCTB were 214 and 232/100,000 persons per year (py), respectively. The ratio
of the passive to active case finding was 1:0.96 (45/43). For every TB case identified through the existing passive
case diagnosis, there was an almost equal number (0.96) of undiagnosed infectious TB cases in the community.
A family history of TB contact was independently associated with a high risk of TB (TB prevalence, AOR, 13; 95% CI:
6.55–15.33) and (TB incidence, aIRR 4.11, 95% CI: 2.18–7.77).
Conclusions and recommendations: The prevalence and incidence of smear-positive and bacteriologically
confirmed TB cases were high in the study area. For every case of smear-positive TB receiving treatment, there
was an almost equal (0.96) number of undetected infectious bacteriologically confirmed TB case in the community.
The high proportion of undetected infectious TB cases in the community could possibly be due to the sub-optimal
performance of Directly Observed Treatment Short-course (DOTS) in detecting 70% of infectious TB cases, as well
as attaining a cure rate of 85% in the study area. Family history of TB contact has substantaially increased the risk
of developing the disease, and there is a need to improve ways of identifying TB cases and intensify mechanisms
of tracing contacts among household members of PTB+ cases.
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Background
Even though highly effective first-line short-course regi-
mens that can cure about 90% of tuberculosis (TB) cases
have been available for decades, the disease remains a
major cause of morbidity and the second leading cause
of death worldwide. Only in 2014,there were an esti-
mated of 9.6 million TB incidents and 1.5 million deaths
due to the disease worldwide [1–3].
In 1993, the World Health Organization (WHO) de-
clared TB to be a global public health emergency and in
1994 formally launched the Directly Observed Treatment
Short-course (DOTS) as a standard strategy to control the
disease [4]. Since then significant progress has been made
in reversing the incidence of TB and it was possible to re-
duce its prevalence by 41% worldwide [5]. However, in
sub-Saharan Africa and other resource-constrained coun-
tries, the number of new TB cases reported is steadily
increasing. Moreover, 80% of TB cases and 78% of global
TB deaths occur in these countries, primarily due to the
high prevalence of human immuno-deficiency virus
(HIV), poor TB control efforts, social inequalities, drug
resistance and inadequate access to TB care [4–6].
The incidence and prevalence of TB are among the
valuable epidemiological indicators used to measure the
impact of TB control efforts and assess the progress
made towards the Millennium Development Goals
(MDGs) [7–9]. A recent systematic review has shown
that the current fixed value of the annual risk of TB in-
fection derived using the Styblo rule in the estimation of
TB incidence in the community is no longer valid in the
era of the HIV epidemic due to the fact that the inci-
dence of TB cases is fuelled by the powerful interaction
between tuberculosis and HIV [9, 10]. Hence, the true
TB incidence and prevalence in the community could
only be obtained through population-based surveys and
prospective follow-up studies that measure the impact of
TB control efforts in a particular country [8]. However,
these types of data are lacking in developing countries
including Ethiopia [11, 12].
Moreover, estimating the incidence of TB is a chal-
lenge due to the fact that enrolling many people in a
prospective follow-up study is difficult [8]. As a result,
two consecutive community-based prevalence surveys
within a short time interval is an alternative option [8].
However, deriving TB incidence from prevalence surveys
requires a good estimate of disease duration, which is
difficult to obtain from such surveys. In general, the true
TB incidence can be measured by either conducting a
prospective follow-up study or by carrying out two con-
secutive prevalence surveys within a short time interval,
and then estimating the number of new TB cases that
occurs between the surveys [7–9].
According to the global TB report of 2015, the TB
prevalence and incidence in Ethiopia were estimated at
190 (95% CI: 160–240) and 200 (95% CI: 160–240),
respectively [1]. Moreover, the 2011 National TB Preva-
lence Survey and other reports from different parts of
the country showed that the TB prevalence ranged
between 30 and 213.4 per 100,000 population [12–18].
However, the real burden of smear-positive pulmonary
TB and bacteriologically confirmed TB cases in Arsi
Zone, in general, and Hetosa District, in particular, was
not known. Thus, the aim of this study was to measure
the prevalence of bacteriologically confirmed pulmonary
TB at the baseline survey, and then to investigate the in-
cidence of TB through a prospective follow-up study in
the Hetosa District of Arsi Zone, Central Ethiopia.
Methods
Study setting
The Hetosa District is one of the 25 districts of Arsi
Zone, Oromia Regional State of Central Ethiopia. The
district is typical of the zone in terms of population
density, socio–cultural and economic state, and demo-
graphic conditions. Therefore, it is expected that the
results could be generalized to the whole zone. Based on
the 2007 Census Projection, the district has an estimated
population of 178,229 living in one urban and 23 rural
kebeles (the smallest administrative unit in the govern-
ment structure) where an average of 2.7 adults were liv-
ing in each household [19]. Since 2010, each kebele in
the district has been further divided into six sub-kebeles
in the rural areas and 10 sub-kebeles in the urban cen-
tres. The sub-kebeles are known as garees. The garees of
the district total to148 (138 from rural and 10 from
urban kebeles) [20]. This study was carried out in 49
randomly selected garees (clusters).
Study design and population
A population-based cross-sectional survey using multi-
stage cluster sampling method was used to estimate the
prevalence of smear-positive TB (PTB+) and bacterio-
logically confirmed TB (BCTB) cases at baseline. Next, a
prospective follow-up study design was employed to
estimate the incidence of the disease. In the estimation
of PTB+ and BCTB incidence, individuals who were free
of a persistent cough for more than two weeks, fever,
loss of appetite, weight loss, blood-stained sputum and
chest pain or difficulty in breathing [symptoms suggest-
ive of TB (SSPTB)] at baseline, and those who had
SSPTB at baseline but later showed negative result in a
bacteriological test, were adopted as a cohort for the
prospective follow-up study. The study was carried out
from July 2013 to June 2014.
The source population for the study were adult indi-
viduals aged ≥15 years and permanently living in the dis-
trict. Eligibility criteria were age ≥15 years, willingness to
provide written consent to participate in the study, and a
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permanent residence for at least 15 days in the selected
house prior to the start of the study. Additionally, partic-
ipants had to be individuals with SSPTB.
Sample size and sampling techniques
For economic and practical reasons, and because it is
typical of the whole of Arsi Zone, the Hetosa District
was purposefully selected from the 25 districts in the
zone. All the 23 rural and one urban kebeles of the
district were included in the study. The number of eli-
gible population in the urban kebele was 5,903, and the
population in the 23 rural kebeles was 27,170. Moreover,
18 of the rural kebeles have higher population density
compared to the remaining five. Each of the former
kebele has about double the population size of each of
the latter. The number of clusters (garees) allocated to
each urban and rural kebele was proportional to its
population size. Consequently, a stratified multi-stage
random sampling procedure was used to select two gar-
ees from each of the 18 rural kebeles high population
density, and one garee from each of the remaining five
rural kebeles. Moreover, based on the urban population
of 5,903 and rural population of 27,170 that fulfilled the
eligibility criteria, eight garees from the urban and 41
from the rural kebeles were included in the study [20].
An alphabetically arranged list of garees in each kebele
along with their population size was obtained from the
district authorities. Subsequently, garees were randomly
selected from the list and included in the study. All indi-
viduals aged ≥15 years residing in the selected garees
were included in the study.
The prevalence of PTB+ used in the sample size calcu-
lation was 382 per 100,000 based on the assumption that
has been used in the 2011 national prevalence survey of
the adult population aged ≥15 years [21], and an esti-
mated 210/100,000 in 2012 for Ethiopia by the WHO
[22]. Consequently, we calculated the sample size using
a prevalence of 382 per 100,000, a relative precision of
0.25, an expected participation rate of 90% and a design
effect of 2, a sample size of 33,448 people from 49 clus-
ters. However, in the house-to-house enumeration held
during the pre-survey of all the 49 selected garees,
34,707 adults aged ≥ 15 years were identified. As the
number was very similar to that of the calculated sample
size, we enrolled all of them in the study.
Data collection procedures
The aims of the study and the procedures for data collec-
tion were discussed with zonal, district and kebele leaders.
The District TB Coordinator selected 24 nurses and 24
health extension workers (HEWs) for data collection, five
laboratory technicians for sputum sample collection and
10 health officers for supervision. A health extension
worker (HEW) is a female community health worker
trained for one-year and deployed at a kebele with the
responsibility of providing essential health services to
ensure equitable access to health care, prevent major com-
municable diseases and promote health in the community
[23]. Altogether, a total of 48 data collectors, five labora-
tory technicians and 10 supervisors were trained on TB
screening techniques and on how to collect and transport
sputum specimens. As on average about 2.7 adult were
living in each household, each data collector was respon-
sible to interview for about 11 to 12 study participants
from four to five households with in a day.
The baseline survey to determine the prevalence of
PTB+ and BCTB was conducted in May to June 2013.
Subsequently, the prospective follow-up study to deter-
mine the incidence of PTB+ and BCTB was carried out
between July 2013 and June 2014. Individuals who met
the eligibility criteria, and were willing to provide written
consent to participate in the study were included.
Study participants with SSPTB were identified as pre-
sumptive TB cases and were interviewed about their age,
sex, history of contact with known TB patients and any
current or previous TB treatment both at the baseline
survey and prospective follow-up study. Participants
with any SSPTB were requested to submit two sputum
samples, one on the spot and the other in the morning
of the following day. Upon receipt from the participants,
the specimens were immediately put in sterile flacon
tubes and placed in a cold box at 4°C and transported
on the same day to the Adama Regional Research Centre
Laboratory.
The following day each smear was fixed, air-dried and
stained using the standard Ziehl-Neelsen (ZN) methods
[24] and examined by experienced laboratory technicians
for the presence of acid-fast bacilli (AFB). Positive re-
sults were quantified using the International Union
against Tuberculosis and Lung Disease (IUATLD) stan-
dards [25]. A senior laboratory technologist blinded to
the first test results re-examined all the smear-positive
and 10% of the smear-negative slides. However, no dis-
cordant test results were observed between the two
examinations. Moreover, sputum cultures using
Lowenstein-Jensen (LJ) medium were commenced
within a maximum of two days from the receipt of the
sputum. In the event the diagnostic test did not com-
mence on the 2nd day following specimen collection,
the sputum sample was stored at −20°C in the same
laboratory until tests were undertaken.
The data collectors also checked TB patient registra-
tion units in the study area to verify that those who
reported they were on anti-TB treatments at the time of
the study were actually on medication, and if there was
any patient who was on anti-TB medication but did not
report it during the survey period. However, no mis-
match was identified.
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Pulmonary smear-positive TB (PTB+) is defined as a
patient found to be positive for AFB in both spot and
morning sputum samples examined using direct micros-
copy or a patient found to be smear-positive in either
spot or morning sputum examinations for AFB and
culture-positive. Further, bacteriologically confirmed TB
(BCTB) cases are individuals with smear- and/or
culture-positive results. Types of TB were defined based
on the 2011 WHO Tuberculosis Prevalence Survey
Handbook [26] as follows:
New case not on treatment
A patient who has never received TB treatment for more
than a month and who is not being treated currently
with any anti-TB drugs.
New case on treatment
A patient who is currently being treated with anti-TB
drugs, but has previously not received any anti-TB treat-
ment for more than a month.
Previously treated case not on treatment
A patient who has previously received treatment for TB
for more than a month, but who is currently not receiv-
ing any treatment with anti-TB drugs.
Previously treated case on treatment
A patient who has previously received treatment for TB
for more than a month and who is currently being
treated with anti-TB drugs.
The sputum smear-positive results were communicated
through both written and telephone reports to TB focal
persons at health centres in the study sites. The diagnosed
TB cases started anti-TB treatment according to the na-
tional TB guidelines [24], with a culture performed on
morning specimens using Lowenstein-Jensen (LJ)
medium. The results were considered to be negative if no
colonies were identified after eight weeks of incubation.
Positive results from the LJ cultures were confirmed by
testing for the presence of AFB through microscopic
examination using the Ziehl-Neelsen method.
In the follow-up study, a total of 32,800 individuals
who were free from SSPTB at baseline study and those
with SSPTB but negative bacteriological results during
the same survey were followed up for 12 months (July
2013 to June 2014) so as to estimate the incidence of
PTB+ and BCTB cases. At intervals of six months, both
at the end of the sixth and the 12th months from the
baseline study, the same data collectors revisited all
households that had been visited at the baseline and
interviewed each person aged ≥15 years. The same data
collection procedure, sputum sample collection, labora-
tory testing procedures and questionnaire were used in
the prospective follow-up study. To ensure the data
quality, the principal investigator and supervisors closely
monitored the data collection process.
Data entry and analysis
All data collected using the standardized and pre-tested
questionnaire were coded and double-entered into Epi-
info version 7 statistical software. The data were checked
against the original questionnaires for missing variables,
and errors were corrected by referring to the original
questionnaires. Data analyses were performed based on
the method recommended by the WHO Tuberculosis
Prevalence Survey Handbook for the estimation of PTB+
and BCTB prevalence [26]. In the initial model of analysis,
the crude PTB+ and BCTB prevalence was estimated
without taking into account the sample cluster survey de-
sign effect. Nonetheless, in the final model, a complete
analysis with an inverse probability weighting was carried
out using robust standard errors to account for the sample
cluster survey design effect, and the adjusted estimated
prevalence of both PTB+ and BCTB were computed and
reported [26]. Data analysis was carried out using STATA
(v12.1, Stata Corporation, College Station, TX, USA).
Furthermore, in the analysis of TB incidence, a
persons per year observation (pyo) was used as a de-
nominator where person-time at risk of TB began in
June 2013 when eligible individuals started participating
in the study. Enrolment ended when participants were
found to be AFB and/or culture-positive and were cen-
sored in June 2014. However, as the exact time of contri-
bution of those who dropped out in the course of the
study due to out-migration or death was not known, we
excluded 185 participants (17 deaths, 47 refusal cases
and 119 out-migrants) from the analysis to avoid bias
due to ambiguity surrounding the time of their contribu-
tion. In order to avoid an under estimation of TB
incidence, the principal investigator checked all health
facilities in the study area to verify whether any TB cases
were diagnosed and registered during the 12 months of
the follow-up study, but none was found.
The prevalence and incidence of PTB+ and BCTB
were taken as the dependent variables whereas age, sex,
area of residence and family history of TB contact were
the independent variables. The independent and
dependent variables were further categorized into groups
for analysis. A Poisson regression analysis was carried
out in the analysis of TB incidence. The estimated inci-
dence rate ratios (IRRs) and adjusted odds ratio (AOR)
at 95% confidence intervals (CI) and P-values of less
than 0.05 were used to assess the strength of association
with PTB+ and BCTB cases as the outcome.
Ethical considerations
The study protocol was reviewed and approved by both
the Regional Committee for Medical and Health Research
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Ethics in Western Norway (REK Vest) and the Institu-
tional Review Board Committee at the Oromia Health
Bureau, Ethiopia. All participants were informed that tak-
ing part in the study was based fully on their willingness,
and that they had the right to quit at any time from the
study. Before any interview started, in the prevalence sur-
vey and in the subsequent follow-up study written con-
sents were obtained from all participants aged ≥18 years
and from parents/guardians if participants were <18 years
of age. Data on individuals were analysed and anonym-
ously reported. Immediate referrals were arranged for par-
ticipants found to be smear or culture-positive, and all
started anti-TB treatment at health centres close to them.




A total of 63,312 individuals were enumerated during
the pre-survey census (Fig. 1). Of these, 34,707 were eli-
gible and thus participated in the prevalence survey. Of
participated, 33,073 (95.3%) were screened for SSPTB.
The average number of eligible individuals who partici-
pated from each cluster was 674.9. The mean age of the
screened individuals was 33.3 years (standard deviation;
SD 16.2) and the median age was 30.3 years. The overall
response rate was 95.3%, with 95.8% for females and
94.8% for males. The overall participation rate was over
the 90% expected in the study design. However, a higher
participation rate among rural clusters (97.6%) was seen
compared to the urban ones (85.9%). Out of the total of
34,707 eligible individuals, 1,634 (4.7%) did not partici-
pate in the prevalence survey. Of the latter, 1,489
(91.1%) were not at home, while 145 (8.9%) were not
willing to participate in the survey (Table 1 and Fig. 1).
Screening and sputum submission
A total of 33,073 eligible individuals were screened for
SSPTB in the prevalence survey. Of these, 27,173 (82%)
were rural residents and 16,907 (51.1%) were males.
Moreover, a total of 32,800 individuals were enrolled for
the follow-up study (Table 1). Of these, 31,802 were free
of SSPTB at the baseline survey, while 998 showed
SSPTB but yielded a bacteriologically negative result. A
total of 1,041 and 1,468 individuals at the baseline sur-
vey and during the follow-up study, respectively, were
reported to have SSPTB. These provided two sputum
samples for bacteriological examination (AFB micro-
scopic examination and culture). Of the former group,
258 (24.8%) individuals reported previous history of TB
treatment, but were not on anti-TB treatment at the
time of the survey. However, 45 known PTB+ cases were
diagnosed through passive TB case findings and had
been on anti-TB treatment at the time of the study.
These also provided two sputum samples for bacterio-
logical examination. Fig. 2 summarizes the screening
and subsequent bacteriological examination results.
TB cases identified
A total of 1,041 individuals with SSPTB and 45 PTB+
cases known to be on anti-TB treatment at the baseline
survey provided spot and morning sputum samples for
bacteriological examination. Of the 1,041 presumptive
TB cases, 43 were found to have bacteriologically con-
firmed TB (culture and/or smear positive) whereas none
of the 45 individuals on anti-TB treatment showed a
positive result (Fig. 1).
The mean (SD) age of the diagnosed TB cases was 30
(10.3) years and the median was 30.8 years. Of the 43
bacteriologically confirmed TB cases, 36 were both
smear- and culture-positive while seven were smear-
negative but culture-positive. From the 36 smear-
positive TB cases, 12 (33.3%) had a family history of TB
contacts (Table 2).
Furthermore, 32,800 individuals were enrolled in the
follow-up study. Of these, 32,759 were followed for 12
months, making 393,108 person-months of observation,
and 41 were diagnosed with TB at the end of the sixth
month making 246 person-months of observation.
Overall, a total of 393,354 person-months or 32,779.5
person-years (py) were observed. Of the total of 393,354
person-months or 32,779.5 py observed, 76 bacterio-
logically confirmed TB cases were identified (41 at the
end of the sixth month and 35 at the end of the 12th
month). Of these, 70 were smear- and culture-positive
while the remaining six were smear-negative but
culture-positive (Fig. 1 and Table 3).
Prevalence
The adjusted prevalence estimate of PTB+ individuals
among adults aged ≥15 years was 109 (95% CI: 67.2–
150.5) whereas that of BCTB was 132 (95% CI: 83.0–
176.2) per 100,000 population. Even so, the adjusted
prevalence of BCTB was higher among females (148.5)
(95% CI: 81.1–210.4) than males (112.2) (95% CI: 55.8–
170.2) but had no statistical difference (Table 2).
In the multivariate logistic regression model, age and
family history of TB contacts were independently associ-
ated with high rates of PTB+ and BCTB cases.
Compared to individuals in the age group from 15–24
years, those in the age group from 25–34 years were 3.4
times more likely to have TB [AOR: 3.4 (95% CI: 1.4–
8.6)]. Those in the age group of 35–44 years were 4.2
times more likely [AOR: 4.2 (95% CI: 1.7–10.2)] while
those ≥45 years were 2.7 times more likely to have the
disease [AOR: 2.7 (95% CI: 1.1–6.7)]. The prevalence of
TB therefore increased with age up to 44 years but de-
clined from 45 years onward. Presumptive TB for those
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Fig. 1 Study flow chart showing the study participants, screening procedure, sputum smear and culture results, Hetosa District, Arsi Zone of
Oromia Region, Central Ethiopia 2016
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who had a family history of contact with TB patients was
13 times more likely than those without such a history
[OR = 13.0, (6.5–25.3)].
The active and passive TB case findings of the study
area were compared using the number of cases identified
by each method. Forty-three BCTB cases were identified
through current active TB case findings while 45 PTB+
cases on anti-TB treatment at the time of the survey
were detected through passive case findings. Of the 45
PTB+ cases, 28 were males while 17 were females mak-
ing a ratio of 1:0.61 (28/17). The male to female ratio for
those identified through active case findings was 0.79:1
(19/24). The ratio of passive to active case findings was
1:0.96 (45/43) (Table 1).
Incidence of smear-positive TB
From the total of 393,354 person-months (32,779.5 py)
observed, 76 BCTB cases were identified. Of these, 70
were both smear- and culture-positive, while six were
smear-negative but culture-positive. The incidence rate
of PTB+ among adult individuals aged ≥15 years was
214 (95% CI: 163.5–263.5) whereas that of BCTB was
232 (95% CI: 179.7–283.9)/100,000 py in the study area
(Table 3). There were 17 adult deaths, 47 refusals and
121 out-migrations during the study period and these
were excluded from the analysis. Moreover, because the
TB status of 1,634 individuals who did not participate in
the baseline survey was not known, they were also
excluded from the follow-up study (Fig. 1).
The incidence of PTB+ cases among males was 215
(95% CI: 144.8–285.3) whereas it was 212 (95% CI:
140.7–283.2) among females per 100,000 py. Likewise,
the incidence of PTB+ per 100,000 py among urban resi-
dents was 222 (95% CI: 101.5–343.4) while it was 212
(95% CI: 156.7–266.5) among rural people. However, the
difference in the incidence rates among males and
females (adjusted incidence rate ratio) [aIRR, 1.22 (95%
CI: 0.78–1.93], and among urban and rural dwellers
[aIRR, 1.23 (95% CI: 0.71–2.14)] was not statistically sig-
nificant (Table 3).
In the multivariate Poisson regression model, the age
and history of TB contact were independently associated
with a high risk of TB. Presumptive TB cases in the age
group from 35–44 years were 2.4 times [aIRR, 2.40 (95%
CI: 1.18–4.55)] more likely to have TB compared to
those in the younger age group from 15–24 years.
Table 1 Participation of eligible individuals in the prevalence survey, Hetosa District of the Arsi Zone of Oromia Region, Central Ethiopia
Variable No. of eligible individuals identified through
census and expected to participate
No. of eligible individuals who participated in
the survey and were screened
Proportion of screened participants
from the total eligible population
Sex
Male 17,834 16,907 94.8
Female 16,873 16,166 95.8
Total 34,707 33,073 95.2
Age
15–24 12,115 11,691 96.5
25–34 8,331 7,889 94.7
35–44 5,959 5,697 95.6
≥45 8,302 7,796 93.9
Mean age 33.3 (SD 16)
Total 34,707 33,073 95.2
Stratum
Rural 27,838 27,170 97.6
Urban 6,869 5,903 85.9
Total 34,707 33,073 95.2
PTB+ identified through passive case findings
Male 28 Male to Female ratio
Female 17
Total 45 1: 0.61
Number of BCTC identified by the survey
Male 19 Male to Female ratio
Female 24
Total 43 0.79:1
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Table 2 Prevalence of smear-positive and bacteriologically-confirmed pulmonary TB among population aged ≥15 years, Hetosa Dis-
trict of Arsi Zone of Oromia Region, Central Ethiopia
Category Number of
participants




















Male 16,907 16 89 (48.3–141.0) 89 (42.2–147.1) 19 112 (62.0–163) 112.2 (55.8–170.2.) 1.00
Female 16,166 20 124 (69.5–177.9) 124 (63.4–184.0) 24 149 (89.1–215.0) 148.5 (81.9–210.4) 1.3 (0.71–2.43)
Age
15–24 11,691 5 43 (5.3–80.3) 43 (4.1–81.3) 8 68 (26.3–92.2) 68 (19.1–99.4) 1.00
25–34 7,889 12 152 (66.1–238.1) 152 (60.0–244.2) 13 165 (75.2–254.0) 165 (68.0–261.2) 3.4 (1.38–8.61)
35–44 5,697 11 193 (79.1–307.1) 193 (73.0–313.2) 11 193 (79.1–307.2) 193 (72.0–314.4) 4.2 (1.71–10.20)
≥45 7,796 8 103 (31.5–237.7) 103 (25.4–233.8) 11 141 (57.8–224.4) 141 (50.6–231.6) 2.76 (1.14–6.72)
Residence
Urban 5,903 5 85 (10.5–159) 85 (4.4–165.1) 9 153 (104.2–254.0) 153 (97.0–261.2) 1,23 (0.59–2.57)
Rural 27,170 31 114 (73.9–154.2) 114 (67.5–160.3) 34 125 (97.3–224.4) 125 (90.1–231.6) 1.00
History of TB contact
NO 31,170 24 77 (42.0–107.7) 77 (36.0–113.8) 31 98 (65.2–133.8) 98 (58.0–141.0) 1.00
Yes 1,867 12 643 (280.2–1005.2) 894 (274.1–1011.3) 12 643 (280.2–1005.2) 643 (273.0–1012.4) 13.0 (6.55–15.33)
Total 33,037 36 109 (73.3–144.3) 109 (67.2–150.5) 43 130.2 (91.2–169) 130.2 (83–176.2)
NB. *Adjusted prevalence estimate of PTB+ and BCTB analysed using robust standard errors to account for the sample survey design
Table 3 Study population, smear-positive TB cases identified over 12 months and incidence rate per 100,000 persons per year,
Hetosa District, Arsi Zone of Oromia Region, Central Ethiopia
Category Person-year Smear-positive Pulmonary Tuberculosis (PTB+)
(n = 70)



















Male 16,741 36 215 (144.8–285.3) 1.00 38 227 (156.7–299.2) 1.00
Female 16,038.5 34 212 (140.7–283.2) 1.22 (0.78–1.93) 38 237 (161.6–312.3) 1.26 (0.80–1.97)
Age
15–24 11,631.5 16 138 (70.2–205) 1.00 19 163(64.1–236.8) 1.00
25–34 7,865 8 102 (31.2–172.2) 1.30 (0.64–2.67) 9 114 (39.7–189.2) 1.51(0.73–3.15)
35–44 5,514 20 363 (203.7–521.7) 2.40 (1.18–4.55) 21 381(218.0–543.7) 2.76 (1.38–5.52)
≥45 7,769 26 335 (206.0–463.3) 1.66 (1.44–4.91) 27 348 (216.4–478.6) 3.05 (1.63–5.71)
Residence
Urban 5,843.5 13 222 (101.5–343.4) 1.00 16 274(139.6–408.0) 1.00
Rural 26,936 57 212 (156.7–266.5) 1.23 (0.71–2.14) 60 223(166.4–279.10 1.25 (0.72–2.16)
History of TB contact
NO 31,138 50 161 (116.1–205.1) 1.00 56 180(132.7–217.6) 1.00
Yes 1,641.5 20 1218 (686.4–1752.4) 4.11 (2.18–7.77) 20 1218(686.4–1752.4) 5.11 (2.63–9.96)
Total 32,779.5 70 214 (163.5–263.5) 76 232(179.7–283.9)
Hamusse et al. BMC Infectious Diseases  (2017) 17:214 Page 8 of 13
Compared to the same age group, those aged ≥45 were
2.7 times [aIRR 2.66 (95% CI: 1.44–4.91)] more likely to
develop the disease. Presumptive TB cases who were ei-
ther free of SSPTB or showed negative bacteriological
examination results at the baseline survey but had history
of contact with TB patients in the family were four times
more likely to have TB than those with no history of such
contact [aIRR, 4.11 (95% CI: 2.18–7.77)] (Table 3).
Discussion
This population-based study identified a high prevalence
and incidence of PTB+ and BCTB among individuals
aged ≥15 in Hetosa District of Arsi Zone. For every TB
case of PTB+ on treatment, there was an almost equal
number (0.96) of undetected bacteriologically confirmed
infectious TB cases in the community. The overall crude
prevalence point estimate of PTB+ and BCTB cases was
very similar to the inverse probability weighting preva-
lence point estimate using robust standard errors to
account for the cluster survey sample design effect. Even
so, there was a difference in precision with a wide confi-
dence interval for the adjusted prevalence point esti-
mate. The adjusted prevalence estimate of PTB+ and
BCTB cases in the study area was 109 (95% CI: 67.2–
150.5) and 130.2 (95% CI: 83.0–176.2)/100,000 popula-
tion, respectively. In the follow-up study, the incidence
of PTB+ and BCTB was 214 (95% CI: 163.3–263.5) and
232 (95% CI: 179.7–283.9)/100,000 py.
The 130.2/100,000 adjusted prevalence estimate of
BCTB cases identified in this study is higher than the
34/100,000 reported from China and the 76/100,000
from Southwest Ethiopia [12]. Nonetheless, it is lower
than the 169/100,000 report from Northern Ethiopia
[27] and the 278/100,000 from the Lao PDR [28].
Moreover, the 109/100,000 adjusted prevalence of PTB
+ cases in this study is similar to the 108/100,000 report
of the national estimate [29]. Conversely, it is higher
than previous reports that ranged from 30 to 80/100,000
population in different parts of the country [12, 14, 30],
the 90/100,000 from Eritrea [31] and the 95/100,000
from Bangladesh [32]. Still, it is lower than the145/
100,000 population reported from Vietnam [33], and the
169/100,000 population reported from Northern
Ethiopia [27] and India [34].
The difference in the prevalence of BCTB and PTB+
TB cases across different geographic settings might be
due to differences in the populations studied, the timing
of the study or differences in the sampling, data collec-
tion and screening methods used across the different
studies. For example, in some studies [12, 14, 30] the
heads of households were interviewed to give testimony
about the TB symptomatic cases of all family members
in the household. However, the heads of households may
not have sufficient information about all individual
members while others interviewed all members of a
household to screen presumptive TB cases [13, 29].
Some community-based TB prevalence studies used
clinical diagnoses and chest x-rays before taking sputum
for screening [29, 35, 36] while others, including the
current study, used TB symptom-screening question-
naires [12–14, 36] to identify the cases. Nonetheless, the
chances of detecting TB cases among non-symptomatic
individuals increased by 20–50% when a combination of
a TB symptom-screening questionnaire and a clinical
diagnosis with a chest x-ray was employed, compared to
using a TB symptom-screening questionnaire alone
without a chest x-ray [7, 28, 29, 35, 37]. Hence, the ad-
justed estimate of BCTB prevalence in this study might
be underestimated due to the fact that the chest x-ray
screening method was not used to identify non-
symptomatic TB cases.
The age group in the survey also varied across differ-
ent studies. Some covered all age groups ≥15 years [29,
30, 32, 38] while others included those aged >14 years
[14] and still others those aged 14 years [12, 13]. Conse-
quently, a comparison of TB prevalence rates among
studies within a country or elsewhere should be taken
with caution.
The high prevalence of BCTB cases among younger
age groups in this study is in agreement with a previous
report [29], whereas the high prevalence of TB among
the younger population may suggest ongoing TB trans-
mission in the community. The prevalence of TB in-
creased with age among the younger age groups up to
the age of 45 years. However, a high TB incidence rate
was observed among the older age group. This might be
due to the high number of infectious TB cases identified
at baseline, which could reduce the ongoing TB trans-
mission among the general population, while the high
TB incidence among the elderly is probably indicative of
a latent TB reactivation among the older age group [13,
14, 29, 39]. Nevertheless, further study is required to
fully understand why the observed high TB prevalence
among younger individuals also corresponded to a high
incidence in the older age group.
In this study, 43 BCTB cases were identified through
active TB case findings at the baseline survey while 45
PTB+ cases were identified through existing passive TB
case findings. Thus, the ratio of PTB+ cases being
treated at the time of the survey to newly detected
BCTB cases was 1:0.96 suggesting that for every PTB+
case receiving treatment during the survey, there was an
almost equal number (0.96) of cases of BCTB existing in
the community. This indicated that there was a very
high proportion of undiagnosed infectious TB cases
present in the community. In Southern Ethiopia, there
were two cases [14] while in South Africa there were 4.5
cases [40] of passive detection for every TB case
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identified through active case findings. In Northern
Ethiopia, the ratios of passive to active TB case findings
were 2.5:1 [30] and 2:1 [13]. This implies that there is a
high number of undiagnosed infectious TB cases in the
present study area compared to reports by previous
studies. The high proportion of undetected infectious
TB cases in the community might be due to the sub-
optimal DOTS performance in identifying 70% of infec-
tious TB cases and attaining the global target of 85%
cure rate in Ethiopia [41–43].
Moreover, the difference in the number of undetected
infectious TB cases across different geographic settings
might be attributed to variation in DOTS performance,
DOTS service coverage and the quality of DOTS ser-
vices across various study areas. It could also be attrib-
uted to the difference in DOTS service uptake that
might result from differences in public awareness about
TB. Consequently, the decentralization and strengthen-
ing of the community in TB care could help to pick up
undetected infectious TB cases in Arsi Zone.
The male-to-female ratio among PTB+ cases identified
through existing passive TB case findings was 1:0.61 (28/
17) whereas the ratio among BCTB cases identified by the
current active TB case finding was 0.79:1 (19/24). This
may indicate a lower rate of passive case findings among
females compared to males. The lower passive and higher
active TB case findings among women in this study is in
agreement with reports from Southern [14] and Northern
Ethiopia [13, 27], Bangladesh [44] and India [34] where
more women were identified through active TB case find-
ings. The lower passive TB case findings among females
might be due to poor access to health services, and as
shown in a study conducted in South Africa, women are
less likely to be asked for a sputum sample when they ap-
pear at health facilities [45]. Moreover, their economic de-
pendence and low health-care seeking behaviour possibly
hindered women from visiting health institutions to obtain
TB care services. Barriers to accessing health services
among TB patients and a failure to detect women with TB
through the routine TB control programme warrant fur-
ther inquiry.
As expected, history of TB contact increased the risk
of having active TB. A recent systematic review and pre-
vious reports have shown that history of TB contact was
associated with a high risk of TB [30, 46–48]. Findings
by the current study are in line with those of a system-
atic review and large epidemiological surveys that have
established the association between history of TB con-
tact and higher risk of TB [47, 49, 50]. Therefore,
contact-tracing efforts should target households with
members who are PTB+ so as to capture the undetected
infectious TB cases in the community.
In this study, the high prevalence of BCTB cases in
urban areas confirms previous reports of high TB
prevalence in urban settings [16, 51, 52]. In contrast, the
national prevalence TB survey reported higher TB preva-
lence among dwellers in the rural areas [29]. This is due
to the inclusion in the national prevalence survey of pas-
toralists in the rural population where the highest preva-
lence ratio of 170/100,000 was observed [21] as opposed
to the current study. The pastoralist population may
have poor access to TB care, as well as low awareness
and health-seeking behaviour which might have resulted
in them having a high burden of undiagnosed TB cases
and eventually elevating the prevalence of TB among the
rural population in the national prevalence survey. The
higher prevalence of BCTB cases among urban settings
compared to rural areas in the current study may be due
to the overcrowded living conditions and dichotomy of
higher HIV prevalence in the urban areas of the country.
The 214/100,000 py incidence rate of PTB+ cases in
this study is similar to the 212/100,000 py reported from
South Africa [53]. However, it is higher than the 197/
100,000 py from Guinea-Bissau [54] and the 207/
100,000 py from Southern Ethiopia [15]. Nonetheless, it
is lower than the 311/100,000 py reported from North-
ern Ethiopia [11]. The high incidence of TB in the
present study might be an indication of the ongoing
transmission of the disease that might result from a sub-
optimal DOTS performance in the interruption of TB
transmission. For instance, according to previous re-
ports, there was a low rate of PTB + case detection rate
(37.7%) [41] and a low cure rate (66.9%) [42] and a high
prevalence of drug resistance TB [55] in the study area.
Hence, the low PTB+ case detection rate, cure rates and
high drug resistance TB reported from the study area,
combined with the high prevalence and incidence rates
identified by the current study, may confirm the sub-
optimal performance of DOTS in curbing the active
transmission of TB. Therefore, the involvement of health
extension workers in educating the community on TB as
well as accelerating referral of presumptive TB cases
may improve the possibility of capturing undiagnosed
infectious TB cases in the community.
Information on the prevalence and incidence of TB is
a valuable epidemiological indicator to help assess the
impact of national and international TB control efforts.
Nevertheless, community-based data on BCTB preva-
lence and incidence are lacking in developing countries
including Ethiopia. As a result, the findings of this study
with regard to the prevalence and incidence rates of
BCTB cases are among the very few population-based
studies in resource-poor settings.
In this study, efforts were made to maintain the quality
of the study, and rigorous training was given for data
collectors and laboratory technicians. The study popula-
tion was monitored to identify deaths and migrations
during the prospective follow-up study to provide an
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accurate time contribution in the denominator to com-
pute the incidence rate. Moreover, we have used very
sensitive standardized and pre-tested questionnaires to
screen presumptive TB cases experienced and qualified
laboratory technicians to carry out smear microscopy
and sputum culture. Following that, a senior laboratory
technologist who was blinded to the results of the first
test results re-examined all the smear-positive, and 10%
of the smear-negative slides, to validate the quality of
laboratory results. Additionally, the estimated design ef-
fect we have used in this study was 2 whereas the actual
calculated design effect from the current study data was
1.3 there by indicating that the sample size of our study
was adequate and is representative of the study popula-
tion of the district. Likewise, in order to obtain the
adjusted precision of PTB+ and BCTB prevalence of the
study, the design effect for the cluster sample survey was
taken into account during the analysis.
On the other hand, although our study was among the
very few attempts to detect a community-based TB inci-
dence and may contribute valuable information to the
TB control programme in Ethiopia, it has some limita-
tions. First, SSPTB was used as screening mechanism.
The fact that chest x-ray was not used in our study
might underestimate the prevalence and incidence of TB
in the area. The missing diagnosed TB cases at the base-
line survey but which were later included in the pro-
spective study might have resulted in an over-estimation
of the TB incidence rate. Second, we excluded 20 con-
taminated sputum cultures from the analysis at the base-
line survey and this may also have led to an
underestimation of the prevalence of sputum culture TB.
Third, we carried out a survey three times, first at the
beginning of the study to determine the prevalence of
TB, followed by the second at the end of the sixth
month and the third at the end of the 12th month to es-
timate incidence of TB. However, the six-month time
interval between surveys may have given sufficient time
for spontaneous self-cure of active TB cases, which
might have led to underestimation of the true incidence
of TB cases in the study area. Fourth, we excluded 1,634
individuals who did not participate in the baseline
survey from the subsequent follow-up study. Moreover,
47 individuals who refused to participate in the follow-
up study plus 18 deaths and 119 out-migrants were
excluded from the analysis of the incidence rate due to
the fact that the exact time of their contribution to the
denominator was not known. Nonetheless, the overall
proportion of participants excluded was only 5.5% and
their baseline socio-demographic characteristics were
similar to those included in the analysis. Therefore, their
exclusion may not affect the overall findings of the
study. Fifth, although HIV is a known risk factor for TB,
we did not screen presumptive TB cases for HIV to
measure the impact of HIV in fueling TB in the study
area. Sixth, some relevant variables that might have af-
fected the outcomes of interest were not included in the
study. Hence, stratifying and analyzing only those in-
cluded variables is less likely to fully control for other
possible confounding variables and may introduce bias.
Conclusions and recommendations
The prevalence and incidence of smear-positive and bac-
teriologically confirmed TB cases were high in the study
area. For every case of smear-positive TB receiving treat-
ment, there was an almost equal number (0.96) of un-
detected infectious bacteriologically confirmed TB cases
in the community. The high proportion of undetected
infectious TB cases in the community could have re-
sulted from the sub-optimal DOTS performance in de-
tecting 70% of infectious TB cases and attaining a cure
rate of 85% in the study area. For this reason, there is a
need to design an alternative strategy to improve TB
case findings. A family history of contact has substantai-
ally increased the risk of developing the disease, so there
is a need to improve the identification of TB cases and
intensify contact tracing among household members of
PTB+ cases through the involvement of community-
based health extension workers.
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